617 related articles for article (PubMed ID: 28079289)
1. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
2. Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.
diFlorio-Alexander RM; Marotti JD; Bond JS; Schwab MC; Memoli VA; Wells WA; Poplack SP
AJR Am J Roentgenol; 2015 Jan; 204(1):211-8. PubMed ID: 25539259
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Magnetic Resonance-Guided Vacuum-Assisted Large-Volume Breast Biopsy (MR-Guided VALB).
Schrading S; Strobel K; Keulers A; Dirrichs T; Kuhl CK
Invest Radiol; 2017 Mar; 52(3):186-193. PubMed ID: 27861232
[TBL] [Abstract][Full Text] [Related]
4. Papillary and sclerosing lesions of the breast detected and biopsied by MRI: Clinical management, upgrade rate, and association with apocrine metaplasia.
Ring NY; diFlorio-Alexander RM; Bond JS; Rosenkranz KM; Cervantes E; Sohn JH; Marotti JD
Breast J; 2019 May; 25(3):393-400. PubMed ID: 30945398
[TBL] [Abstract][Full Text] [Related]
5. Pathologic Findings of Breast Lesions Detected on Magnetic Resonance Imaging.
Jabbar SB; Lynch B; Seiler S; Hwang H; Sahoo S
Arch Pathol Lab Med; 2017 Nov; 141(11):1513-1522. PubMed ID: 28782985
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging-guided breast biopsy in lesions not visualized by mammogram or ultrasound.
Oxner CR; Vora L; Yim J; Kruper L; Ellenhorn JD
Am Surg; 2012 Oct; 78(10):1087-90. PubMed ID: 23025947
[TBL] [Abstract][Full Text] [Related]
8. Upgrade Rate and Imaging Features of Atypical Apocrine Lesions.
Chang Sen LQ; Berg WA; Carter GJ
Breast J; 2017 Sep; 23(5):569-578. PubMed ID: 28333404
[TBL] [Abstract][Full Text] [Related]
9. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
Orel SG; Rosen M; Mies C; Schnall MD
Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of MR-guided Vacuum-Assisted Breast Biopsy: 8 Years of Experience.
Ferré R; Ianculescu V; Ciolovan L; Mathieu MC; Uzan C; Canale S; Delaloge S; Dromain C; Balleyguier C
Breast J; 2016; 22(1):83-9. PubMed ID: 26511082
[TBL] [Abstract][Full Text] [Related]
11. The Positive Outcome of MRI-Guided Vacuum Assisted Core Needle Breast Biopsies Is Not Influenced by a Prior Negative Targeted Second-Look Ultrasound.
Ferré R; AlSharif S; Aldis A; Mesurolle B
Can Assoc Radiol J; 2017 Nov; 68(4):401-408. PubMed ID: 28835335
[TBL] [Abstract][Full Text] [Related]
12. MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes.
Bissell MB; Keshavarsi S; Fleming R; Au F; Kulkarni S; Ghai S; Freitas V
Breast Cancer Res Treat; 2024 May; 205(1):159-168. PubMed ID: 38305940
[TBL] [Abstract][Full Text] [Related]
13. MR imaging appearance of noncalcified and calcified DCIS.
Scott-Moncrieff A; Sullivan ME; Mendelson EB; Wang L
Breast J; 2018 May; 24(3):343-349. PubMed ID: 29139591
[TBL] [Abstract][Full Text] [Related]
14. High-risk lesions at MRI-guided breast biopsy: frequency and rate of underestimation.
Lourenco AP; Khalil H; Sanford M; Donegan L
AJR Am J Roentgenol; 2014 Sep; 203(3):682-6. PubMed ID: 25148176
[TBL] [Abstract][Full Text] [Related]
15. Apocrine carcinoma vs. apocrine metaplasia with atypia of the breast. Use of aspiration biopsy cytology.
Yoshida K; Inoue M; Furuta S; Sakai R; Imai R; Hayakawa S; Fukatsu T; Nagasaka T; Nakashima N
Acta Cytol; 1996; 40(2):247-51. PubMed ID: 8629406
[TBL] [Abstract][Full Text] [Related]
16. Mammographic-pathologic correlation of apocrine metaplasia diagnosed using vacuum-assisted stereotactic core-needle biopsy: our 4-year experience.
Kushwaha AC; O'Toole M; Sneige N; Stelling CB; Dryden MJ
AJR Am J Roentgenol; 2003 Mar; 180(3):795-8. PubMed ID: 12591698
[TBL] [Abstract][Full Text] [Related]
17. MRI-guided vacuum-assisted breast biopsy: experience of a single tertiary referral cancer centre and prospects for the future.
Penco S; Rotili A; Pesapane F; Trentin C; Dominelli V; Faggian A; Farina M; Marinucci I; Bozzini A; Pizzamiglio M; Ierardi AM; Cassano E
Med Oncol; 2020 Mar; 37(5):36. PubMed ID: 32221708
[TBL] [Abstract][Full Text] [Related]
18. MRI-guided breast biopsy: outcomes and effect on patient management.
Myers KS; Kamel IR; Macura KJ
Clin Breast Cancer; 2015 Apr; 15(2):143-52. PubMed ID: 25499596
[TBL] [Abstract][Full Text] [Related]
19. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging.
Torous VF; Resteghini NA; Phillips J; Dialani V; Slanetz PJ; Schnitt SJ; Baker GM
Arch Pathol Lab Med; 2021 Oct; 145(10):1264-1269. PubMed ID: 33450753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
